GC
Guyer Charles Greg
Directeur Exécutif
OtherM
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Guyer Charles Greg, Directeur Exécutif. Insider active across 1 company, notably Biomarin Pharmaceutical INC. In total, 20 reports have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €2.4m. Activity tracked since 30 April 2021. The latest transaction was filed on 17 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Guyer Charles Greg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
1,693 shares@ US$56.052.5% of flowCommon StockSEC:0001628280-26-019857:0
9,109 shares@ US$58.5112.5% of flowCommon StockSEC:0001628280-26-019012:0
16,486 shares@ US$60.4618.8% of flowCommon StockSEC:0001628280-26-017447:0
6,176 shares0Common StockSEC:0001628280-26-012542:0
20,127 shares@ US$69.4440.6% of flowCommon StockSEC:0001048477-25-000031:0
7,034 shares@ US$71.27614.7% of flowCommon StockSEC:0001048477-25-000025:0
4,287 shares@ US$71.169.3% of flowCommon StockSEC:0001048477-25-000021:0
11,040 shares0Common StockSEC:0001048477-25-000017:0
55 shares@ US$56.0070.1% of flowCommon StockSEC:0001048477-24-000154:0
245 shares@ US$68.6460.5% of flowCommon StockSEC:0001048477-24-000077:0
10,550 shares0Common StockSEC:0001048477-24-000046:0
20,840 shares0Common StockSEC:0001048477-24-000024:0
133 shares@ US$69.2330.3% of flowCommon StockSEC:0001048477-23-000051:0
5,360 shares@ US$93.30414.4% of flowCommon StockSEC:0001048477-23-000035:0
239 shares@ US$66.880.5% of flowCommon StockSEC:0001209191-23-027934:0
8,900 shares0Common StockSEC:0001567619-23-005299:0
6,205 shares@ US$96.5618.5% of flowCommon StockSEC:0001567619-22-015499:0
243 shares@ US$62.4070.0001% mcap38.8% of flowCommon StockSEC:0001567619-22-009719:0
11,040 shares0Common StockSEC:0001567619-22-007183:0
221 shares@ US$62.4070.2% of flowCommon StockSEC:0001567619-21-009154:0
About Guyer Charles Greg
Guyer Charles Greg is Directeur Exécutif and EVP, Chief Technical Officer at Biomarin Pharmaceutical INC, listed on XNAS. He has 20 filings in total, and across the 20 sampled filings between 2021-05-05 and 2026-03-19, the reported amounts are EUR 0 in buys and EUR 2365974 in sells, with the modal transaction nature shown as Attribution.